BridgeBio Oncology Therapeutics, Inc. (BBOT) stock
BBOTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.14−0.21 (-8.94%)
Close on Nov 13, 2026Market cap $171.57MP/E –Yield –
BridgeBio Oncology Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
BridgeBio Oncology Therapeutics's price to book ratio was 0.6× on Nov 11, 2026, against 2.2× a year earlier.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.6× | −1.6 |
| 2025 | Dec 31, 2025 | 2.2× | – |
See a number that looks wrong?